Ausgabe 1/2015
Inhalt (25 Artikel)
Improving breast cancer services for African-American women living in St. Louis
Lailea Noel, Shahnjayla K. Connors, Melody S. Goodman, Sarah Gehlert
Prognostic and functional importance of the engraftment-associated genes in the patient-derived xenograft models of triple-negative breast cancers
Hyeong-Gon Moon, Keunhee Oh, Jiwoo Lee, Minju Lee, Ju-Yeon Kim, Tae-Kyung Yoo, Myung Won Seo, Ae Kyung Park, Han Suk Ryu, Eun-Jung Jung, Namshin Kim, Seongmun Jeong, Wonshik Han, Dong-Sup Lee, Dong-Young Noh
FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index
Christina Yau, Laurence Meyer, Stephen Benz, Charles Vaske, Gary Scott, Brian Egan, Paul Labhart, Nader Pourmand, Christopher C. Benz
Paclitaxel-induced transcriptional regulation of Fas signaling pathway is antagonized by dexamethasone
Martin Crozier, Lisa A. Porter
Differential expression of epithelial–mesenchymal transition and stem cell markers in intrinsic subtypes of breast cancer
Victoria Pomp, Cornelia Leo, Andrea Mauracher, Dimitri Korol, Wenjun Guo, Zsuzsanna Varga
Development of triple-negative breast cancer radiosensitive gene signature and validation based on transcriptome analysis
Alimujiang Wushou, Yi-Zhou Jiang, Jing Hou, Yi-Rong Liu, Xiao-Mao Guo, Zhi-Ming Shao
Osteopontin promotes aromatase expression and estradiol production in human adipocytes
Lukas Leitner, Alexander Jürets, Bianca K. Itariu, Maike Keck, Gerhard Prager, Felix Langer, Viktor Grablowitz, Maximilian Zeyda, Thomas M. Stulnig
Is a higher boost dose of radiation necessary after breast-conserving therapy for patients with breast cancer with final close or positive margins?
Betro T. Sadek, Gelareh Homayounfar, Rita F. Abi Raad, Andrzej Niemierko, Mina N. Shenouda, Amany R. Keruakous, Michelle C. Specht, Alphonse G. Taghian
Molecular subtyping improves diagnostic stratification of patients with primary breast cancer into prognostically defined risk groups
Katharine Yao, Robert Goldschmidt, Mary Turk, Jelle Wesseling, Lisette Stork-Sloots, Femke de Snoo, Massimo Cristofanilli
Paclitaxel, bevacizumab, and everolimus/placebo as first-line treatment for patients with metastatic HER2-negative breast cancer: a randomized placebo-controlled phase II trial of the Sarah Cannon Research Institute
Denise A. Yardley, Linda D. Bosserman, Joyce A. O’Shaughnessy, William N. Harwin, Susan K. Morgan, Victor M. Priego, Nancy W. Peacock, J. David Bass, Howard A. Burris III, John D. Hainsworth
Complete blood counts, liver function tests, and chest x-rays as routine screening in early-stage breast cancer: value added or just cost?
Raphael J. Louie, Jennifer E. Tonneson, Minda Gowarty, Philip P. Goodney, Richard J. Barth Jr., Kari M. Rosenkranz
Depressive episodes, symptoms, and trajectories in women recently diagnosed with breast cancer
Annette L. Stanton, Joshua F. Wiley, Jennifer L. Krull, Catherine M. Crespi, Constance Hammen, John J. B. Allen, Martha L. Barrón, Alexandra Jorge, Karen L. Weihs
Black breast cancer survivors experience greater upper extremity disability
Lorraine T. Dean, Angela DeMichele, Mously LeBlanc, Alisa Stephens-Shields, Susan Q. Li, Chris Colameco, Morgan Coursey, Jun J. Mao
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy
Grazia Arpino, Carmine De Angelis, Giuseppe Buono, Annamaria Colao, Mario Giuliano, Simona Malgieri, Stefania Cicala, Michelino De Laurentiis, Antonello Accurso, Anna Crispo, Gennaro Limite, Rossella Lauria, Bianca Maria Veneziani, Valeria Forestieri, Dario Bruzzese, Sabino De Placido
Myelodysplastic syndrome and acute myeloid leukemia following adjuvant chemotherapy with and without granulocyte colony-stimulating factors for breast cancer
Gregory S. Calip, Judith A. Malmgren, Wan-Ju Lee, Stephen M. Schwartz, Henry G. Kaplan
Hormone-related pathways and risk of breast cancer subtypes in African American women
Stephen A. Haddad, Kathryn L. Lunetta, Edward A. Ruiz-Narváez, Jeannette T. Bensen, Chi-Chen Hong, Lara E. Sucheston-Campbell, Song Yao, Elisa V. Bandera, Lynn Rosenberg, Christopher A. Haiman, Melissa A. Troester, Christine B. Ambrosone, Julie R. Palmer
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations
Jeffrey S. Ross, Siraj M. Ali, Kai Wang, Depinder Khaira, Norma A. Palma, Juliann Chmielecki, Gary A. Palmer, Deborah Morosini, Julia A. Elvin, Sandra V. Fernandez, Vincent A. Miller, Philip J. Stephens, Massimo Cristofanilli
Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers?
John Semple, Kelly A. Metcalfe, Jan Lubinski, Tomasz Huzarski, Jacek Gronwald, Susan Armel, Henry T. Lynch, Beth Karlan, William Foulkes, Christian F. Singer, Susan L. Neuhausen, Charis Eng, Javaid Iqbal, Steven A. Narod
Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age
Jan C. Drooger, Delal Akdeniz, Jean-Philippe Pignol, Linetta B. Koppert, Danielle McCool, Caroline M. Seynaeve, Maartje J. Hooning, Agnes Jager
onlineDeCISion.org: a web-based decision aid for DCIS treatment
Elissa M. Ozanne, Katharine H. Schneider, Djøra Soeteman, Natasha Stout, Deborah Schrag, Michael Fordis, Rinaa S. Punglia
The readability of online breast cancer risk assessment tools
Sarah Cortez, Melissa Milbrandt, Kimberly Kaphingst, Aimee James, Graham Colditz
Explicating perceived barriers to mammography for the USCREEN project: concerns about breast implants, faith violations, and perceived recommendations
Jakob D. Jensen, Chelsea Ratcliff, Jeremy Weaver, Melinda M. Krakow, William Payton, Sherrie Loewen
Real-life decision-making impact of Oncotype DX
Gianfilippo Bertelli, Simon Holt
Response to real-life decision-making impact of oncotype DX
Federico Augustovski, Natalie Soto, Joaquín Caporale, Lucas Gonzalez, Luz Gibbons, Agustín Ciapponi